Malaysia looks at thalassaemia screening:
This article was originally published in Clinica
The Malaysian government is considering the introduction of a national prevention programme for thalassaemia. Some 15,200 Malaysians are affected by thalassaemia and more than 200 babies are born each year in Malaysia with the severe form of the disease, says Asian Medical News. The programme would include population screening, genetic counselling and antenatal diagnostic testing. More selective use of complex thalassaemia tests was called for recently in Hong Kong to release funds for all pregnancies in the territory to be screened (see Clinica No 687, p 7).
You may also be interested in...
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.